SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-057762
Filing Date
2021-11-09
Accepted
2021-11-09 16:51:55
Documents
13
Period of Report
2021-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea150166-8k_fsdevelop2.htm   iXBRL 8-K 38082
2 AMENDMENT NO. 1 TO MERGER AGREEMENT, DATED AS OF NOVEMBER 7, 2021 ea150166ex2-1_fsdevelop2.htm EX-2.1 26437
  Complete submission text file 0001213900-21-057762.txt   252996

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fsii-20211107.xsd EX-101.SCH 3055
4 XBRL LABEL FILE fsii-20211107_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE fsii-20211107_pre.xml EX-101.PRE 22809
6 EXTRACTED XBRL INSTANCE DOCUMENT ea150166-8k_fsdevelop2_htm.xml XML 3892
Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415 877 4887
FS Development Corp. II (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40067 | Film No.: 211392985
SIC: 2834 Pharmaceutical Preparations